ArticleCardiovascular drugs and therapy2022

Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.

Dhruv Mahtta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.